Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…
Citigroup Upgrades Bio-Techne to Buy, Raises Price Target to $100
Citigroup analyst Patrick Donnelly upgrades Bio-Techne (NASDAQ:TECH) from Neutral to Buy and raises the price target from $81.25 to $100.
RBC Capital Initiates Coverage On Bio-Techne with Sector Perform Rating, Announces Price Target of $89
RBC Capital analyst Conor McNamara initiates coverage on Bio-Techne (NASDAQ:TECH) with a Sector Perform rating and announces Price Target of $89.
Stephens & Co. Maintains Overweight on Bio-Techne, Adjusts Price Target to $105 – 4-for-1 Stock Split
Stephens & Co. analyst Jacob Johnson maintains Bio-Techne (NASDAQ:TECH) with a Overweight, adjusts price target to $105 - 4-for-1 stock split.
SVB Leerink Maintains Outperform on Bio-Techne, Lowers Price Target to $500
SVB Leerink analyst Puneet Souda maintains Bio-Techne (NASDAQ:TECH) with a Outperform and lowers the price target from $550 to $500.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
Credit Suisse Initiates Coverage On Bio-Techne with Outperform Rating, Announces Price Target of $465
Credit Suisse analyst Dan Leonard initiates coverage on Bio-Techne (NASDAQ:TECH) with a Outperform rating and announces Price Target of $465.